Aptamer-functionalized liposomes for targeted cancer therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Aptamer-functionalized liposomes for targeted cancer therapy

Published:2019-04 Issue: Volume:448 Page:144-154
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Moosavian Seyedeh Alia,Sahebkar Amirhossein

Funder

cancer research center of cancer institute of Iran

Biotechnology Development Council of the Islamic Republic of Iran

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference121 articles.

1. Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress;Lammers;J. Contr. Release : Off. J. Contr. Release Soc.,2012

2. Delivering nanomedicine to solid tumors;Jain;Nat. Rev. Clin. Oncol.,2010

3. Cancer nanomedicine: progress, challenges and opportunities;Shi;Nat. Rev. Canc.,2017

4. Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer;Malam;Trends Pharmacol. Sci.,2009

5. Anti-CD19-Targeted liposomal doxorubicin improves the therapeutic efficacy in murine B-cell lymphoma and ameliorates the toxicity of liposomes with varying drug release rates;Allen;Clin. Cancer Res.,2005

Cited by 151 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microfluidic-enabled aptamer-modified liposomal probes for targeted transient triplet differential photoacoustic imaging;Sensors and Actuators B: Chemical;2024-12

2. Aptamer-controlled stimuli-responsive drug release;International Journal of Biological Macromolecules;2024-11

3. Stimuli-responsive nanotheranostic systems conjugated with AIEgens for advanced cancer bio-imaging and treatment;Journal of Controlled Release;2024-09

4. Current trends in triblock copolymer-based multifunctional nanotheranostics for cancer treatment;Journal of Drug Delivery Science and Technology;2024-09

5. RGD-decorated nanoparticles: Therapeutic potential beyond cancer;Journal of Drug Delivery Science and Technology;2024-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3